3[1]Yokoyama Ⅰ, Yonekura K, Ohtake T, et al. Coronary microangiopathy in type 2 diabetic patients:Relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease. J Nucl Med 2000,41:978～985
4[2]Pitkanen OP, Nuutila P, Kaitakari OT,et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes, 1998,47:248 ～254
5[3]Porter TR, Xie F, Kricsfeld A, et al. Noninvasive identification of acute myocardial ischemia and reperfusion with contrast ultrasound using intravenous perfluoropane-exposed sonicated detrose albumin. J Am Coll Cardiol, 1995,26: 33 ～ 40
6[4]Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998,97: 473～483
7[5]Brodsky SV,Morrishow AM, Dharia N ,et al. Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol 2001,280:F480～486～
8[6]Yokoyama Ⅰ,Ohtake T, Monomura S,et al. Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes 1998,47:119～124
9[1]Porter TR, Xie F,Kricsfeld A. Noninvasive identification of acute myocardial infarction and reperfusion with contrast ultrasound using intravenous perfluropropane-exposed sonicated dextrose albumin[J]. J Am Coll Cardiol, 1995, 26(1):33-40.
10[3]Villaneva FS, Glasheen WP, Sklenar J, et al. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast[J]. Circulation,1993, 88(2): 596-604.
